OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
PIK3CA mutation as an acquired resistance driver to EGFR-TKIs in non-small cell lung cancer: Clinical challenges and opportunities
Xiaohong Liu, Wuxuan Mei, Pengfei Zhang, et al.
Pharmacological Research (2024) Vol. 202, pp. 107123-107123
Open Access | Times Cited: 8
Xiaohong Liu, Wuxuan Mei, Pengfei Zhang, et al.
Pharmacological Research (2024) Vol. 202, pp. 107123-107123
Open Access | Times Cited: 8
Showing 8 citing articles:
A computer-aided, carrier-free drug delivery system with enhanced cytotoxicity and biocompatibility: a universal model for multifunctional lung cancer therapy
Zhonglei Wang, Wenjing Xu, Shizeng Lei, et al.
Colloids and Surfaces B Biointerfaces (2025) Vol. 250, pp. 114557-114557
Closed Access
Zhonglei Wang, Wenjing Xu, Shizeng Lei, et al.
Colloids and Surfaces B Biointerfaces (2025) Vol. 250, pp. 114557-114557
Closed Access
Cetuximab chemotherapy resistance: Insight into the homeostatic evolution of head and neck cancer (Review)
Carlos Henrique Diniz, Tiago Henrique, Ana Carolina Buzzo Stefanini, et al.
Oncology Reports (2024) Vol. 51, Iss. 6
Open Access | Times Cited: 3
Carlos Henrique Diniz, Tiago Henrique, Ana Carolina Buzzo Stefanini, et al.
Oncology Reports (2024) Vol. 51, Iss. 6
Open Access | Times Cited: 3
Regulation, Functional Impact, and Therapeutic Targeting of APOBEC3A in Cancer
Ajinkya S. Kawale, Lee Zou
DNA repair (2024) Vol. 141, pp. 103734-103734
Closed Access | Times Cited: 1
Ajinkya S. Kawale, Lee Zou
DNA repair (2024) Vol. 141, pp. 103734-103734
Closed Access | Times Cited: 1
Acquired resistance to tyrosine kinase targeted therapy: mechanism and tackling strategies
Defa Wu, Qian Sun, Hongjun Tang, et al.
Drug Resistance Updates (2024) Vol. 78, pp. 101176-101176
Closed Access
Defa Wu, Qian Sun, Hongjun Tang, et al.
Drug Resistance Updates (2024) Vol. 78, pp. 101176-101176
Closed Access
A good response to furmonertinib fourth-line treatment of an advanced lung adenocarcinoma patient with EGFR exon20in and PIK3CA mutation: a case report and literature review
Kai Sun, Peng Wang
Frontiers in Oncology (2024) Vol. 14
Open Access
Kai Sun, Peng Wang
Frontiers in Oncology (2024) Vol. 14
Open Access
Design, Synthesis, and Pharmacological Evaluation of Triazine-based PI3K/mTOR Inhibitors for the Potential Treatment of Non-Small Cell Lung Cancer
Ming Zeng, Ying-xuan Hu, Lan Zhao, et al.
European Journal of Medicinal Chemistry (2024) Vol. 284, pp. 117200-117200
Closed Access
Ming Zeng, Ying-xuan Hu, Lan Zhao, et al.
European Journal of Medicinal Chemistry (2024) Vol. 284, pp. 117200-117200
Closed Access
39. UNG THƯ PHỔI KHÔNG TẾ BÀO NHỎ CÓ ĐỒNG THỜI ĐỘT BIẾN GEN EGFR VÀ PIK3CA: KẾT QUẢ ĐIỀU TRỊ BƯỚC ĐẦU TẠI BỆNH VIỆN PHỔI TRUNG ƯƠNG GIAI ĐOẠN 2022-2024
Lê Tú Linh, Đinh Văn Lượng, Đặng Duy Hiếu, et al.
Tạp chí Y học Cộng đồng (2024) Vol. 65, Iss. CD3
Open Access
Lê Tú Linh, Đinh Văn Lượng, Đặng Duy Hiếu, et al.
Tạp chí Y học Cộng đồng (2024) Vol. 65, Iss. CD3
Open Access
Phenotypic plasticity in a novel set of EGFR tyrosine kinase inhibitor-adapted non-small cell lung cancer cell lines
Tharsagini Nanthaprakash, Campbell W. Gourlay, Ina Oehme, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Tharsagini Nanthaprakash, Campbell W. Gourlay, Ina Oehme, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
